Neurawell Therapeutics, Inc.
Sunny Isles Beach, US · Delaware corporation · 1 known investors
Founders & leadership
MA
Magid AbrahamExecutive Officer, Director
TI
Tom InselExecutive Officer, Director
JA
Jack AbrahamDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.6MraisedJun 2024 · 4 investors · Other TechnologyRule 506(b)
▶$1.6MraisedJun 2024 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jack AbrahamDirector
- Magid AbrahamExecutive Officer, Director
- Tom InselExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.6M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.